CVS Stock Recent News

CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above, saying some members would pay $0 premium monthly for prescription drugs.

CVS Health Corp (NYSE:CVS) is exploring options to split its retail and insurance divisions in response to investor pressure, according to a Reuters exclusive. The potential separation, which may lead to two publicly traded entities, would reverse CVS's $70 billion acquisition of Aetna.

Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company — among them a potential breakup — the Wall Street Journal reported on Monday.

CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.

CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. CEO Lynch's leadership is under scrutiny, with hedge fund Glenview Capital pushing for strategic changes, potentially including management overhaul, and requesting meetings with senior management. Despite current struggles, CVS's long-term potential remains, hinging on improving Medicare Advantage margins and avoiding further downgrades.

“Sell at former peaks” is an old Wall Street expression. People say this because stocks tend to run into resistance when they rally to a price level that has been a peak.

Michael Farr, Hightower Advisors chief market strategist, joins 'Power Lunch' to discuss stock plays for three stocks.

Gathering signals potential changes to improve shareholder value after the company's weak stock performance.

Glenview Capital has amassed a sizable stake in CVS Health and plans to meet with the company's top executives to lay out its plan for value creation, according to people familiar with the matter. The proposal is seen as a precursor to an activist push at the company, the people said.

The hedge fund has taken a large position in the healthcare company, which has seen its shares fall 24% this year to date